Guidance on quality requirements for biocides: Overview

On this page

Purpose

You are required to provide information in your biocide application so that the Minister of Health (the Minister) can determine if the biocide's benefits outweigh its risks taking into account any uncertainties relating to those benefits and risks. This requirement is set out in both the Food and Drugs Act (act) and Biocides Regulations (regulations).

This guidance document outlines the tools and approaches you can use to meet the quality requirements set out in the regulations so that biocides made available for sale in Canada are of good quality. Using these tools and approaches may reduce the number of times we need to clarify an item in an application. It will make a decision on your biocide more quickly.

This guidance is for people who work with biocides as:

You are responsible for ensuring that:

You should contact us if you wish to deviate from the approaches in this guidance. If you do deviate from this guidance, you should include the following in your application, as applicable:

When deviating from the described methods, standards and/or limits, you should provide:

General

If the Minister does not have sufficient information to conclude that the benefits of your biocide outweigh its risks, taking into consideration any uncertainties, we will either:

Examples of situations where we may request additional quality information include:

Examples of additional quality information that could be requested to better characterize the benefits and risks of your biocide include:

For guidance on navigating the biocide application process, consult:

The guidance on management of biocide applications outlines the mechanisms that we can use to request additional information from you during our assessment of your biocide application.

Application requirements

Information to support the risks and any related uncertainties of your biocide includes:

Certain applications must contain quality information and/or a summary of the information included in your application about the risks and any related uncertainties of your biocide. Find information below and in the guidance on biocide application pathways and general requirements on when quality data and/or a summary are required, and specific application requirements.

You do not need to include information on your biocide's quality if:

This applies to applications using the:

In all other application pathways, you must include the:

As indicated in the summary of information on benefits, risk and related uncertainties section of the guidance on biocide application pathways and general requirements, the summary helps us screen and review your application. It may also reduce the number of clarification requests we issue, a mechanism outlined in the guidance on management of biocide applications.

Your summary should explain your biocide's quality, including a copy of your biocide's specifications, master formula and stability and shelf life results. It should include a summary of your quality data and other related information (such as rationales) for your proposed biocide.

If possible, you should put the quality summary in a table:

To support the shelf life of the biocide, you may need to provide stability information, including stability studies, in your application. This information may also be required for applications involving a different packaging from a comparison product (comparison - labelling only application) or foreign biocide (UFD application).

Refer to the stability and shelf life page for when stability data is required.

Certain biocides require additional quality information in their application for a market authorization. The Minister needs this information to determine if your biocide's benefits outweigh its risks, taking into account any related uncertainties.

Additional quality information is required for:

Quality control

Relevant section of the regulations: sections 51, 52, 53 and 54

You are responsible for ensuring the quality control of your biocide, including:

The quality of a biocide is an important factor in maintaining the effectiveness of a biocide, as failures in effectiveness can pose risks to health. Quality control is important to help mitigate these risks. The quality control requirements in the regulations provide a modern approach to ensure a final marketed biocide complies with the master formula, without the need for prescriptive regulations governing the manufacturing process.

Similar to the regulation of surface disinfectants under the Food and Drug Regulations, biocides are not required to obtain a drug establishment licence or meet good manufacturing practices (GMP) compliance. However, they are still expected to meet section 8 of the Food and Drugs Act (the act), which prohibits selling drugs manufactured under unsanitary conditions or that are adulterated.

To support compliance with quality control requirements in the regulations and the act, you should consult the information below. The updated recommendations build on the voluntary Standard for the Fabrication, Control and Distribution of Antimicrobial Agents for Use on Environmental Surfaces and Certain Medical Devices (GUI-0049), published by the Regulatory Operations and Enforcement Branch of Health Canada and applicable for disinfectants regulated under the Food and Drug Regulations.

Master formula

Ensure both the manufacturing and the packaging operations are:

We recommend that you maintain your master formula as a single continuous document or record.

The manufacturing master formula should include:

The packaging master formula should include the following for each product, package size and type:

Consult the section on product specifications and package description for more information on specifications.

Batch production record

Your master formula should also include blank spaces to record data during the biocide's production run to show that each manufacturing step has been completed. These blank spaces will capture:

Once you have filled out the master formula and attached supporting data, it becomes the batch production record. You should attach to the master formula supporting data, such as:

Records

If you're a market authorization holder, importer, manufacturer, packager, labeller or provide storage for a biocide, you must maintain records.

These records:

If you are a market authorization holder or importer, you must maintain records that show that each lot or batch of the biocide that you sell has been manufactured, packaged, labelled and stored in accordance with the master formula for the biocide depending on your activity.

If you are a manufacturer, or a packager or labeller, you must maintain records that show that each lot or batch of the biocide that you sell has been manufactured, or packaged and labelled, depending on your activity, and stored in accordance with the master formula of the biocide.

You should have the following documentation:

For records of testing, these should indicate the actual results, methods used and laboratory where testing was done.

Records for packaging material testing should be maintained for packaging components that are:

Documentation may be paper-based, electronic or photographic media.

For information on electronic records, consult PIC/S Annex 11: Computerised systems (adopted by Health Canada). This guidance explains Part C, Division 2 of the Food and Drug Regulations and is not mandatory for biocides.

Records:

Retention period

If you are the market authorization holder, importer or seller (even if you stop engaging in these activities), you must keep records and evidence for at least:

Requirement to provide information

Quality records are not required to be submitted with your biocide market authorization application.

If you are the market authorization holder, importer or seller, you must provide us with quality records when we request them within 5 business days or less as specified.

Documentation must be in English or French.

Personnel

The appropriate personnel with sufficient training are necessary to manufacture, package, import or store biocides of high quality. You should employ qualified personnel to supervise the manufacturing, packaging, labelling, importing and storage of biocides.

These recommendations can help maintain the quality of your biocides, as inadequate qualification or training of personnel may lead to the failure of a biocide to meet its specifications and its quality requirements.

Personnel qualifications are not required to be submitted with your biocide market authorization application.

Qualifications

Individuals in charge of manufacturing and quality control should have adequate education, training and/or practical experience to control and/or supervise activities. This can include:

Individuals in charge of manufacturing and quality control may also delegate their duties to other persons with proper education, training and/or experience.

To ensure that operations involved in the handling of biocides are properly performed, all personnel should have adequate qualifications, including training and/or experience. This includes individuals responsible for:

A variety of documents can provide evidence of sufficient training and/or experience necessary to perform assigned duties, including:

Premises

Buildings where a biocide will be manufactured, packaged, labelled, imported and/or stored should be designed and constructed in a manner that permits cleanliness and orderliness, while preventing contamination. Regular maintenance will also help to prevent deterioration of the premises.

The objective is to ensure products do not become contaminated through unsanitary conditions.

These recommendations can help prevent the contamination of biocides by other products, dust, cleaning agents or foreign materials.

Specific information on premises is not required to be submitted with your biocide market authorization application.

Building design

You should design, construct and maintain your premises to prevent the introduction or migration of extraneous materials, insects or other animals into biocides. An appropriate building design can help you ensure activities related to biocides are being conducted in a sanitary way. This includes:

Designated spaces

Clearly designated spaces can prevent cross-contamination where different activities are being conducted in the same building. Production and non-production areas should:

Regular maintenance, verification and monitoring of the facility and equipment can reduce the likelihood of contaminants introduced into the environment being transferred to products. This includes:

Equipment

Contamination issues may arise from inadequate cleaning practices, poor maintenance, misusing equipment, exceeding the capacity of equipment and using worn-out equipment. These recommendations can help prevent the contamination of biocides by other products, dust, cleaning agents or foreign materials coming from the equipment.

Specific information on equipment is not required to be submitted with your biocide market authorization application.

Equipment that's arranged in an orderly manner allows for effective cleaning and prevents interference with other processing operations. It also minimizes the circulation of personnel and optimizes the flow of materials.

All processing, packaging and testing equipment should be designed and located in a way that permits ready and thorough cleaning, sanitizing and inspection. This includes:

Establishing and following procedures for cleaning and maintaining equipment can help you ensure the equipment remains in a good state of repair when in use to prevent contamination of the biocide. Procedures should include:

Investigation of complaints

Relevant section of the regulations: sections 48, 49, 50, 51, 52, 53 and 54

As part of its regulatory responsibilities, the Regulatory Operations and Enforcement Branch of Health Canada monitors compliance, undertakes enforcement actions, and works towards preventing non-compliance through compliance promotion activities. The interpretation of the scope of the compliance and enforcement policy for health products (POL-0001) has been expanded to include biocides.

If you receive a complaint about the quality of the biocide, you must document and investigate it and, if necessary, take corrective action. This applies to authorization holders or importers, as well as manufacturers, packagers or labellers of a biocide.

When investigating complaints, suspected product defects and other problems related to the quality of the biocide should:

When a decision is made to recall a product, you must notify Health Canada as per section 49 of the regulations. For additional information on recall requirements, refer to the Drug, natural health product and biocide recall guide (GUI-0039).

Where required, you should have an agreement in place between the various parties involved in investigations and corrective actions (importer, market authorization holder, manufacturer, packager or labeller). This agreement should define each party's responsibilities in assessing quality and taking any corrective and preventative actions.

Such agreements cannot be used to transfer your obligations under the regulations. If an agreement is in place, the person responsible for the activity should be clearly spelled out.

Note:

  • If a complaint requires corrective action by another person (such as the manufacturer), the complaint should be reported to the person responsible for addressing the quality issue or the market authorization holder.
  • If ownership has been transferred, the new market authorization holder must continue investigations and corrective actions that have not been completed by the previous market authorization holder.

Records - complaints, investigations and corrective actions

If you are the authorization holder, importer, manufacturer, packager or labeller of a biocide, you must maintain a record of each complaint, investigation and any corrective action taken.

You must maintain records of:

You should review complaint records regularly to check if specific or recurring problems are occurring and need attention.

Retention period - records of complaints, investigations and corrective actions

If you are the authorization holder, importer, manufacturer, packager or labeller of a biocide, you must retain and maintain each record of each complaint, investigation and any corrective action taken. This applies even if you no longer hold the market authorization or no longer import the biocide.

Records must be maintained for at least 1 year after whichever is later:

If ownership has been transferred, the new market authorization holder must retain records of investigations and corrective actions that were sent to them.

Requirement to provide information - records of complaints, investigations and corrective actions

If you are the holder of the market authorization, importer, manufacturer, packager or labeller of a biocide, you must provide records of complaints, investigations or corrective actions upon request. They must be provided within 5 business days or less.

We will ask for records sooner if we have reasonable grounds to believe that there is a serious and imminent risk of injury to human health.

Contact us

Contact the Natural and Non-prescription Health Products Directorate to:

Email: nnhpd-dpsnso@hc-sc.gc.ca

Page details

2025-08-13